English
Home > Products > CAS:223673-61-8

China CAS:223673-61-8 Manufacturer

We are also focusing on improving the stuff management and QC system so that we could keep great advantage in the fiercely-competitive business for CAS:223673-61-8, Our organization has been devoting that "customer first" and committed to helping clients expand their small business, so that they become the Big Boss !
CAS:223673-61-8, Our company is working by the operation principle of "integrity-based, cooperation created, people oriented, win-win cooperation". We hope we can have a friendly relationship with businessman from all over the world.

Related Products

Hot Products

  • Finasteride

    Finasteride

    Finasteride has EP, USP, CP, IP, JP specifications. CEP available, FDA, PMDA and GMP approved.

    CAS:98319-26-7

  • Ganciclovir

    Ganciclovir

    Ganciclovir has CP ,EP, USP specification. DMF and GMP approved.

    CAS:82410-32-0

  • 17a-Hydroxyprogesterone Acetate

    17a-Hydroxyprogesterone Acetate

    17a-Hydroxyprogesterone Acetate is an endogenous progesteroid hormone similar to progesterone.

    CAS:302-23-8

  • Lasmiditan Succinate

    Lasmiditan Succinate

    Lasmiditan Succinate has In-house specification. DMF approved.

    CAS:439239-92-6

  • Misoprostol Tablets 0.2mg*3

    Misoprostol Tablets 0.2mg*3

    Misoprostol Tablets 0.2mg*3
    Specifications：0.2mg*3
    Indications：Abortion
  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

  • Related Blog
  • Reviews

  • 2022 CPhI Exhibition Shanghai

    CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

  • Visit us at Milan CPHI - Booth 3A65!

    We're looking forward to welcoming you!

  • Welcome to CPHI Middle East 2024

    CPHI Middle East 2024 will be held in Riyadh from 10 Dec 2024 - 12 Dec 2024. The pavilion is located at Riyadh Front Exhibition & Convention Center Riyadh and our booth number is 3.G43.

  • 2025 Corporate Exhibition Calendar Officially Released !

    Our 2025 Exhibition Calendar has been announced! Come meet our team and explore new business opportunities.We look forward to seeing you there!

  • Welcome to CPhI JAPAN 2025

    CPhI JAPAN 2025 will be held at East Halls 6, Tokyo Big Sight from April 09-11,2025, our booth number is 6C-20a.

  • What Is Dutasteride and How Does It Work to Treat Hair Loss and BPH

    Dutasteride is a powerful 5α-reductase inhibitor widely used in the treatment of benign prostatic hyperplasia (BPH) and increasingly discussed for male pattern hair loss. This article provides a comprehensive overview of what Dutasteride is, how it works at the biochemical level, its benefits, risks, clinical applications, and how it compares with other therapies such as Finasteride.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept